MedPath

Mezzion Pharma Co., Ltd.

Mezzion Pharma Co., Ltd. logo
๐Ÿ‡ฐ๐Ÿ‡ทSouth Korea
Ownership
Public
Established
2002-01-01
Employees
21
Market Cap
-
Website
http://www.mezzion.co.kr

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Phase 3
Recruiting
Conditions
Single Ventricle Heart Disease
Interventions
Drug: Placebo
First Posted Date
2023-06-26
Last Posted Date
2025-04-18
Lead Sponsor
Mezzion Pharma Co. Ltd
Target Recruit Count
436
Registration Number
NCT05918211
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Phoenix Children's Hospital, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Arkansas Children's, Little Rock, Arkansas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Los Angeles, Los Angeles, California, United States

and more 77 locations

Evaluation of Fontan-Associated Liver Disease

Completed
Conditions
Single Ventricle Heart Disease
Interventions
First Posted Date
2018-02-13
Last Posted Date
2025-05-06
Lead Sponsor
Mezzion Pharma Co. Ltd
Target Recruit Count
88
Registration Number
NCT03430583
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital Colorado, Aurora, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

Nemours Cardiac Center/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States

๐Ÿ‡บ๐Ÿ‡ธ

Children's National Medical Center, Washington, District of Columbia, United States

and more 14 locations

A Extension Study of Udenafil in Adolescents

Phase 3
Conditions
Functional Single Ventricle Heart Disease
Interventions
First Posted Date
2017-01-06
Last Posted Date
2020-11-24
Lead Sponsor
Mezzion Pharma Co. Ltd
Target Recruit Count
300
Registration Number
NCT03013751
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Phoenix Children's Hospital/Children's Heart Center at Phoenix Children's Hospital, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Medical University of South Carolina, Charleston, South Carolina, United States

๐Ÿ‡จ๐Ÿ‡ฆ

The Hospital for Sick Children, Toronto, Ontario, Canada

and more 21 locations

Fontan Udenafil Exercise Longitudinal Assessment Trial

Phase 3
Completed
Conditions
Single Ventricle Heart Disease
Interventions
Drug: Placebo
First Posted Date
2016-04-18
Last Posted Date
2025-05-21
Lead Sponsor
Mezzion Pharma Co. Ltd
Target Recruit Count
400
Registration Number
NCT02741115
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Phoenix Children's Hospital/Children's Heart Center at Phoenix Children's Hospital, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins All Children's Heart Institute, Saint Petersburg, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Nemours Cardiac Center/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States

and more 27 locations

Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents

Phase 1
Completed
Conditions
Single Ventricle Heart Disease After Fontan Surgery
Interventions
First Posted Date
2014-07-28
Last Posted Date
2025-05-06
Lead Sponsor
Mezzion Pharma Co. Ltd
Target Recruit Count
36
Registration Number
NCT02201342
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

๐Ÿ‡จ๐Ÿ‡ฆ

The Hospital for Sick Children, Toronto, Ontario, Canada

๐Ÿ‡บ๐Ÿ‡ธ

Riley Hospital for Children, Indianapolis, Indiana, United States

and more 3 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath